The 1-year and 3-year survival rates were 79.2% and 39.5%, respectively. The factors related to survival time were pancreatic cancer (p = 0.01), resection status (p = 0.001) and lymph node metastasis (p = 0.01); long-term morbidity included: diabete 7.5%, digestive disorders 11.3%, hernia 3.8% and cholangitis 3.8%.